Why Recessions Forge Great CEOs Who Think Beyond Cost-Cutting
04/15/2025
No Comments
But the CEOs who make history in downturns aren’t the ones with the deepest cuts
June 21, 2023: On Tuesday, Eli Lilly said it slapped a $2.4 billion contract to develop Dice Therapeutics to stock up its medicine portfolio for immune-related diseases.
Eli Lilly will be spending $48 per share in cash to buy Dice, which shows around a 40% bonus to where the San Francisco-based company’s shares closed on Friday. The transaction is anticipated to close in the third quarter of this year.
Eli Lilly’s stock price increased by over 1% in early morning trading. Dice Therapeutics’ share cost increased over 37% to just under the purchase price.
“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating immune diseases,” stated Patrik Jonsson, Eli Lilly executive vice president, in a press release.
Dice is a biopharmaceutical company that uses a proprietary technology platform to develop reenergized oral therapeutic drugs for autoimmune diseases, in which the body’s immune system erroneously attacks a person’s cells instead of protecting them.
Autoimmune diseases can induce pain, fatigue, dizziness, depression, and rashes, among other symptoms.
Over 100 known autoimmune diseases include lupus, rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
Dice’s lead drug is in a midstage test for an immune-related skin condition called psoriasis.
Eli Lilly’s immunology portfolio includes drugs such as Taltz, which treats plaque psoriasis, and Olumiant, a therapy for rheumatoid arthritis. The previous year, Taltz raked in $2.48 billion, while Olumiant generated $830.5 million in sales.
But the CEOs who make history in downturns aren’t the ones with the deepest cuts
Companies invest millions in leadership development, yet many of their best executives leave within a few years. Why?
The most successful business leaders don’t just identify gaps in the market; they anticipate future needs before anyone else.
With technological advancements, shifting consumer expectations, and global interconnectedness, the role of business leaders
The leadership landscape is profoundly changing, influenced by technological advancements, shifting workforce expectations, and the need for adaptability in an unpredictable global environment.
In the fast-paced business world, corporate leaders often find themselves at the crossroads of risk and reward, where bold decisions …
April 24, 2025: Silicon Valley is experiencing a sharp recalibration in artificial intelligence investment, with signs of AI fatigue emerging across venture capital
April 23, 2025: The Canadian government has introduced new legislation to regulate the use of artificial intelligence in education and healthcare, focusing on accountability,
April 17, 2025: Prime Minister Justin Trudeau s government is under growing political pressure over its current immigration strategy.
But the CEOs who make history in downturns aren’t the ones with the deepest cuts
Leave us a message
Subscribe
Fill the form our team will contact you
Advertise with us
Fill the form our team will contact you
